Also called: IPF · Idiopathic pulmonary fibrosis
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Pulmonary Fibrosis
Pulmonary fibrosis is a condition in which the tissue deep in your lungs becomes scarred over time. This tissue gets thick and stiff. That makes it hard for you to catch your breath, and your blood may not get enough oxygen.
Causes of pulmonary fibrosis include environmental pollutants, some medicines, some connective tissue diseases, and interstitial lung disease. Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. In most cases, the cause cannot be found. This is called idiopathic pulmonary fibrosis.
Symptoms include:
- Shortness of breath
- A dry, hacking cough that doesn't get better
- Fatigue
- Weight loss for no known reason
- Aching muscles and joints
- Clubbing, which is the widening and rounding of the tips of the fingers or toes
Your doctor may use your medical history, imaging tests, a biopsy, and lung function tests to diagnose pulmonary fibrosis. There is no cure. Treatments can help with symptoms and improve your quality of life. They include medicines, oxygen therapy, pulmonary rehabilitation, or a lung transplant.
It sits within Lungs and Breathing.
The lead U.S. institute for this subject is the National Heart, Lung, and Blood Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Pulmonary Fibrosis
2,581 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisContineum Therapeutics
- H01 in Adults With Interstitial Lung Disease (The SOLIS Study)National Institute of Environmental Health Sciences (NIEHS)
- A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisRein Therapeutics
- Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseaseUnited Therapeutics
- A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard TreatmentBoehringer Ingelheim
- A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the BloodBoehringer Ingelheim
Research already completed
- Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory StudyMemorialCare Health System
- Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic FibrosisThe Cleveland Clinic
- HERO-2: Home-Reported Outcomes With CFTR Modulator TherapyIndiana University
- The Role of SGLT2i in Management of Moderate ASUniversity of East Anglia
- A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)Boehringer Ingelheim
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- Introduction to Pulmonary FibrosisAmerican Lung Association
- What Is Idiopathic Pulmonary Fibrosis?National Heart, Lung, and Blood Institute
- What Is Pulmonary Fibrosis?Pulmonary Fibrosis Foundation
Diagnosis and Tests
- Arterial Blood Gas (ABG) TestNational Library of Medicine
- Bronchoscopy and Bronchoalveolar Lavage (BAL)National Library of Medicine
- Lung Function TestsNational Library of Medicine
- SpirometryAmerican Lung Association
- Tests for Lung DiseaseNational Heart, Lung, and Blood Institute
Living With
- Living Well with Pulmonary FibrosisAmerican Lung Association
- Living with Pulmonary Fibrosis FAQAmerican Lung Association
- Maintain Your HealthPulmonary Fibrosis Foundation
- Pulmonary Rehabilitation: MedlinePlus Health TopicNational Library of Medicine
Genetics
- Hermansky-Pudlak syndrome: MedlinePlus GeneticsNational Library of Medicine
- Idiopathic pulmonary fibrosis: MedlinePlus GeneticsNational Library of Medicine
Clinical Trials
- ClinicalTrials.gov: Pulmonary FibrosisNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Pulmonary Fibrosis. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Pulmonary Fibrosis, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.